Analysis of histopathological and immunohistochemical differences of oral squamous cell carcinoma in young and old patients in Sri Lanka

J Oral Pathol Med. 2007 Jul;36(6):357-62. doi: 10.1111/j.1600-0714.2007.00548.x.

Abstract

Background: Oral squamous cell carcinoma (OSCC) most commonly occurs in the middle-aged and older individuals. The purpose of the present study was to evaluate the histopathological and immunohistochemical differences of the younger (<40 years) and the older (more than 50 years) groups.

Methods: The histopathological parameters of 112 patients (younger 56 and older 56) were compared according to three grading systems (Broder JAMA 1920; 74: 656, Anneroth et al. Scand J Dent Res 1987; 95: 229, Bryne et al. J Pathol 1992; 166: 375) and as individual histopathological parameters. Further, the expression of p53 and Proliferative Cell Nuclear Antigen (PCNA) index was also compared.

Results: Although there was no significant difference between two groups regarding the three grading systems, a significantly higher number of nuclear aberrations was found in younger group (P<0.001). Interestingly, higher number of mitoses (P<0.05) and lymph node metastasis (P<0.05) were observed in the older group (P<0.05). Furthermore, significantly a higher PCNA index was found in the older group (P<0.005).

Conclusions: Although tumours of the young patients showed more nuclear aberrations, OSCC of the older patients is proliferative and showed higher metastatic rate.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / secondary
  • Chi-Square Distribution
  • Humans
  • Lymphatic Metastasis
  • Middle Aged
  • Mitosis
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology*
  • Proliferating Cell Nuclear Antigen / metabolism
  • Sri Lanka
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53